Boc-D-Ala(8-Qui)-OH
Need Assistance?
  • US & Canada:
    +
  • UK: +

Boc-D-Ala(8-Qui)-OH

* Please kindly note that our products are not to be used for therapeutic purposes and cannot be sold to patients.

Category
BOC-Amino Acids
Catalog number
BAT-000979
CAS number
1998581-30-8
Molecular Formula
C17H20N2O4
Molecular Weight
316.36
Synonyms
Boc-D-Qal(8)-OH; N-α-(t-Butoxycarbonyl)-β-(8-quinoyl)-D-alanine; (2R)-2-[(2-Methylpropan-2-yl)oxycarbonylamino]-3-quinolin-8-ylpropanoic acid
Storage
Store at 2-8 °C

Boc-D-Ala(8-Qui)-OH, a protected amino acid derivative utilized in peptide synthesis, holds diverse applications in various fields. Here are the key applications, expressed with elevated perplexity and burstiness:

Peptide Synthesis: Serving as a foundational unit in peptide and protein synthesis, Boc-D-Ala(8-Qui)-OH plays a pivotal role. The Boc protecting group present allows for selective deprotection, facilitating the systematic assembly of intricate peptides. This methodical approach is vital for crafting bespoke peptides tailored for both research endeavors and pharmaceutical pursuits, highlighting the intricate dance of molecular construction.

Drug Development: Within the realm of drug discovery, synthetic peptides originating from Boc-D-Ala(8-Qui)-OH emerge as potential therapeutic candidates. These peptides possess the capability to mimic or impede biological molecules, serving as a springboard for the design of novel pharmaceutical agents. The precise incorporation of amino acid derivatives like Boc-D-Ala(8-Qui)-OH enhances the stability and bioactivity of these peptides, underlining the delicate balance in creating effective treatments.

Bioconjugation: Embracing the realm of bioconjugation, Boc-D-Ala(8-Qui)-OH finds utility in fusing peptides with diverse molecules such as drugs, antibodies, or fluorescent tags. This functionalization broadens the scope of peptides in diagnostic and therapeutic domains, introducing a new dimension of precision and efficacy to treatments. Conjugated peptides hold the potential to target specific cells or tissues, ushering in a new era of targeted therapies with intricate molecular connections.

Structural Biology: The incorporation of Boc-D-Ala(8-Qui)-OH into peptides serves as a cornerstone in structural biology endeavors, aiding in crystallography and NMR studies to unravel the intricate structures of proteins and peptides. By synthesizing peptides with defined sequences, researchers can glean high-resolution structural insights, shining a light on protein functions, inhibitor design, and molecular mechanisms in a symphony of molecular exploration.

1. Structural features of the Pip/AzPip couple in the crystalline state: influence of the relative AzPip location in an azadipeptide sequence upon the induced chirality and conformational characteristics
C Didierjean, A Aubry, F Wyckaert, G Boussard J Pept Res. 2000 Apr;55(4):308-17. doi: 10.1034/j.1399-3011.2000.00686.x.
Azapipecolic (AzPip) is a pipecolic (Pip) residue analogue containing a nitrogen atom in place of the C(alpha)H group. AzPip was introduced into two reverse dipeptide sequences, Piv-AzPip-L-Ala-NHiPr I and Boc-L-Ala-AzPip-NHiPr II in order to evaluate, in the crystalline state, the influence of the L-Ala-induced chirality upon the prochiral AzPip residue, and therefore the resulting conformational characteristics, according to the relative position of the AzPip residue. Piv-DL-Pip-NHMe III served as a control derivative for comparison between the properties of the two different heterocycles of Pip and AzPip residues. Piperidine and hexahydropyridazine rings have a few characteristics in common: chair conformation, axial disposition of the C-terminal backbone substituent and the cisoid form of the N-terminal tertiary amide function. An almost pure sp3 hybridization state is observed for the substituted nitrogen atom N(alpha), so that L-Ala induces an AzPip (R) or (S) chirality when it follows or precedes, respectively, the azaresidue in such a pseudodipeptide sequence. If both I and II compounds present a short NH...N contact between the sp2 tertiary amide nitrogen atom and the NH of the next secondary amide function, whatever the chiral nature of the sequence, the heterochiral azadipeptide I adopts a rather totally extended conformation while the homochiral azadipeptide II is folded by a beta-VI turn-like structure stabilized by a classical 4-->1 intramolecular hydrogen bond.
2. Proline-containing beta-turns. IV. Crystal and solution conformations of tert.-butyloxycarbonyl-L-prolyl-D-alanine and tert.-butyloxycarbonyl-L-prolyl-D-alanyl-L-alanine
V S Ananthanarayanan, T S Cameron Int J Pept Protein Res. 1988 Apr;31(4):399-411.
The conformations of the dipeptide t-Boc-Pro-DAla-OH and the tripeptide t-Boc-Pro-DAla-Ala-OH have been determined in the crystalline state by X-ray diffraction and in solution by CD, n.m.r. and i.r. techniques. The unit cell of the dipeptide crystal contains two independent molecules connected by intermolecular hydrogen bonds. The urethane-proline peptide bond is in the cis orientation in both the molecular forms while the peptide bond between Pro and DAla is in the trans orientation. The single dipeptide molecule exhibits a "bent" structure which approximates to a partial beta-turn. The tripeptide adopts the 4----1 hydrogen-bonded type II beta-turn with all trans peptide bonds. In solution, the CD and i.r. data on the dipeptide indicate an ordered conformation with an intramolecular hydrogen bond. N.m.r. data indicate a significant proportion of the conformer with a trans orientation at the urethane-proline peptide bond. The temperature coefficient of the amide proton of this conformer in DMSO-d6 points to a 3----1 intramolecular hydrogen bond. Taken together, the data on the dipeptide in solution indicate the presence (in addition to the cis conformer) of a C7 conformation which is absent in the crystalline state. The spectral data on the tripeptide indicate the presence of the type II beta-turn in solution in addition to the nonhydrogen-bonded conformer with the cis peptide bond between the urethane and proline residues. The relevance of these data to studies on the substrate specificity of collagen prolylhydroxylase is pointed out.
3. Conformational preferences of proline analogues with different ring size
Jong Suk Jhon, Young Kee Kang J Phys Chem B. 2007 Apr 5;111(13):3496-507. doi: 10.1021/jp066835z. Epub 2007 Mar 13.
The conformational study on L-azetidine-2-carboxylic acid (Ac-Aze-NHMe, the Aze dipeptide) and (S)-piperidine-2-carboxylic acid (Ac-Pip-NHMe, the Pip dipeptide) is carried out using ab initio HF and density functional methods with the self-consistent reaction field method to explore the differences in conformational preferences and cis-trans isomerization for proline residue and its analogues with different ring size in the gas phase and in solution (chloroform and water). The change of ring size by deleting a CH2 group from or adding a CH2 group to the prolyl ring results the remarkable changes in backbone and ring structures compared with those of the Pro dipeptide, especially in the C'-N imide bond length and the bond angles around the N-C(alpha) bond. The four-membered azetidine ring can have either puckered structure depending on the backbone structure because of the less puckered structure. The six-membered piperidine ring can adopt chair and boat conformations, but the chair conformation is more preferred than the boat conformation. These calculated preferences for puckering are consistent with experimental results from analysis of X-ray structures of Aze- and Pip-containing peptides. On going from Pro to Aze to Pip, the axiality (i.e., a tendency to adopt the axial orientation) of the NHMe group becomes stronger, which can be ascribed to reduce the steric hindrances between 1,2-substituted Ac and NHMe groups. As the solvent polarity increases, the polyproline II-like conformation becomes more populated and the relative stability of conformation tC with a C7 hydrogen bond between C'=O of the amino group and N-H of the carboxyl group decreases for both the Aze and Pip dipeptides, as seen for the Pro dipeptide. The cis population and rotational barriers for the imide bond increase with the increase of solvent polarity for both the Aze and Pip dipeptides, as seen for the Pro dipeptide. In particular, the cis-trans isomerization proceeds in common through only the clockwise rotation with omega' approximately +120 degrees about azetyl and piperidyl peptide bonds in the gas phase and in solution, as seen for alanyl and prolyl peptide bonds. The pertinent distance d(N...H-N(NHMe)) and the pyramidality of imide nitrogen can describe the role of this hydrogen bond in stabilizing the transition state structure, but the lower rotational barriers for the Aze and Pip dipeptides than those for the Pro dipeptide, which is observed from experiments, cannot be rationalized.
Online Inquiry
Verification code
Inquiry Basket